US5530011AExpiredUtility
4-[(2-benzothiazolyl)methylamino]-α-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol
Est. expiryFeb 14, 2012(expired)· nominal 20-yr term from priority
C07D 417/12
37
PatentIndex Score
1
Cited by
3
References
4
Claims
Abstract
A compound of formula <IMAGE> (I) <IMAGE> the racemic mixture, the (S)-form and the acid addition salts thereof, said compound having anti-stroke properties. Pharmaceutical compositions containing this compound as active ingredient and a method of preparing said compound and pharmaceutical compositions.
Claims
exact text as granted — not AI-modifiedWe claim:
1. A method of treating strokes in patients suffering from the same which comprises administering to said patients an effective anti-stroke amount of a compound of the formula: ##STR13## the racemic mixture, the (S)-form, or a pharmaceutically acceptable acid addition salt thereof.
2. The method of claim 1 wherein the compound of Formula (I) is selected from the group consisting of (S)-4-[(2-benzothiazolyl)methylamino]-α-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol and its dihydrochloride salt.
3. A method of treating warm-blooded newborn patients suffering from postasphyxial brain damage which comprises administering to said patients an effective amount of a compound of the formula: ##STR14## the racemic mixture, the (S)-form, or a pharmaceutically acceptable acid addition salt thereof.
4. The method of claim 3 wherein the compound of Formula (I) is selected from the group consisting of (S)-4-[(2-benzothiazolyl)methylamino]-α-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol and its dihydrochloride salt.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.